Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
NCT00533650 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 227
Last updated 2016-07-29
Summary
A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.
Conditions
- Post-Menopausal Osteoporosis
Interventions
- DRUG
-
MK0429
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-12-31
- Primary Completion
- 2002-10-31
- Completion
- 2002-10-31
More Related Trials
-
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
NCT00532337 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
NCT00089791 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
NCT02157948 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
NCT01495000 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Anabolic Osteoporosis Therapy
NCT05688969 ·Status: RECRUITING ·Phase: NA
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
NCT00504426 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
NCT00729651 ·Status: COMPLETED ·Phase: PHASE4
-
Osteoclast Inhibition and Bone Formation
NCT02554695 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
NCT00996801 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
NCT00091793 ·Status: COMPLETED ·Phase: PHASE3
-
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
NCT00887965 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
NCT00330460 ·Status: COMPLETED ·Phase: PHASE3
-
POWER Point of Care Effect on Satisfaction of Treatment
NCT00549068 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Minodronate in Patients With Low Back Pain
NCT05645289 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
NCT00092027 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)
NCT00863525 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers
NCT00863590 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
NCT00692913 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)
NCT00529373 ·Status: TERMINATED ·Phase: PHASE3
-
TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density
NCT05391776 ·Status: UNKNOWN ·Phase: PHASE1
-
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
NCT02156960 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
NCT00620113 ·Status: COMPLETED ·Phase: PHASE2
-
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
NCT00043186 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Medicine Approach for Osteoporosis - Follow Up Study
NCT06264609 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4